Linkedin-in Facebook-f
Our Portfolio Companies
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
Briefcase Loading...

Archives: Technologies

  • Contact
Add to Briefcase

Novel Molecules for the Local Treatment of Skin Pathologies such as Scleroderma and Psoriasis

The expected outcome from the technology will be a novel local treatment of skin pathologies such as Scleroderma and Psoriasis, that does not attack the immune system and thus could lead to therapeutic benefits, while lowering side-effects. We seek potential collaborations with dermatological and pharma companies for the development of the treatment....
Read more
  • Category: Pharmaceuticals
  • Keywords: HC - Dermatology & Cosmetics, HC - New Chemical Entity

Leader Research:

Prof. Amnon Hoffman

School of Medicine - IMRIC

  • Contact
Add to Briefcase

MAGNA:Mental Assessment by Geometric Network Analysis

An extremely simple and short task provides a recorded 1-minute verbal input for a highly sophisticated analysis that enables the identification and characterization of psychopathology markers...
Read more
  • Category: Computer Science & Engineering, Medical Devices & Digital Health
  • Keywords: Algorithms, Diagnostics, Medical Applications

Leader Research:

Dr. Anat Maril

Faculty of Social Sciences

  • Contact
Add to Briefcase

Organic Six-Bit Spin Memristor

Application Our Innovation A novel metal-organic system for efficient long-range spin-polarization, as a basis for spintronic-based logical devices. Our system is comprised of a chiral phenylalanine-copper crystal, with spin-polarizing properties resulting from a combination of CISS and intrinsic ferromagnetic properties of the crystal. Advantages Opportunity We are seeking collaboration with companies in the semiconductor industry […]...
Read more
  • Category: Chemistry & Nanotechnology
  • Keywords: PS - Device, PS - Microelectronics

Leader Research:

Prof. Yossef Paltiel

School of Computer Science and Engineering

  • Contact
Add to Briefcase

Repurposing Approved Drugs for New Indications

We now propose harnessing our unique approach to discover drugs that fight against various pathogens and disease states. We have already demonstrated that applying our unique AI algorithm has yielded a preliminary list of possible drugs with the promise of affecting various medical conditions....
Read more
  • Category: Medical Devices & Digital Health, Pharmaceuticals
  • Keywords: HC - AI & Bioinformatics, HC - Drug Delivery & Formulation

Leader Research:

Prof. Yuval Tabach

School of Medicine - IMRIC

  • Contact
Add to Briefcase

Repurposing of an Approved Drug for the Inhibition of Tumor Progression

Prof. Shaul’s lab identified a set of genes encoding metabolic enzymes that produce “suppressor metabolites” that are involved in the formation of metastasis.   ...
Read more
  • Category: Pharmaceuticals
  • Keywords: HC - Drug Delivery & Formulation, HC - Oncology & Immunotherapy

Leader Research:

Dr. Yoav Shaul

School of Medicine - IMRIC

  • Contact
Add to Briefcase

Efficient Vegetative Propagation & Rooting Preparations and Protocols for Avocado and Additional Plants

Yissum is looking to partner with a commercial entity to bring these novel rooting products to market and to disrupt the avocado industry....
Read more
  • Category: AgTech

Leader Research:

Prof. Amos Nussinovitch

Faculty of Agricultural, Food and Environmental Quality Sciences

  • Contact
Add to Briefcase

A Novel Embolization Procedure for Cancer Treatment

The synthesis of polymeric drug microspheres is a central challenge in the development of new drug delivery systems, especially for injectable products. The present technology suggests novel and tightly controlled embolic beads that gradually reduce blood perfusion (minimizing normal tissue stress) to the tumor environment while eluting embedded cytotoxic/anti-angiogenic drugs in a sustained manner. This new concept allows gradual embolism for maximal drug elution and minimal tissue stress....
Read more
  • Category: Pharmaceuticals
  • Keywords: HC - Drug Delivery & Formulation, HC - Medical Devices, HC - Oncology & Immunotherapy

Leader Research:

Prof. Ofra Benny

School of Medicine - IMRIC

  • Contact
Add to Briefcase

Synthetic Gene Circuits for CAR -T Cell Therapy

Application:         Our Innovation: TACTIC™ (Tumor-activated Armored CAR-T with Internal Control) Advantages: Commercial Opportunity: Our development program, currently in preclinical studies for HER2-positive breast and colorectal cancers, has a clear pathway to IND submission. To accelerate our progress toward clinical validation, we are raising $10-20M in seed funding to complete animal studies and pre-IND work. This […]...
Read more
  • Category: Pharmaceuticals
  • Keywords: HC - Cell Therapy, HC - Oncology & Immunotherapy, HC - Synthetic Biology

Leader Research:

Dr. Lior Nissim

School of Medicine - IMRIC

  • Contact
Add to Briefcase

Nanoparticle counter in microfluidic flow based on size and antibody interactions

Category Life Sciences and Biotechnology    Keywords Diagnostics, Biomarkers, Infection diseases Current development stage For Pharmaceutical development: TRL4 – PoC&Safety of candidate device or system is demonstrated in a defined lab or animal model ApplicationThe diagnostics field aims at detecting specific biomarkers, some of which point directly to disease stages as well as to infections. However, […]...
Read more
  • Category: Diagnostics, Medical Devices & Digital Health
  • Keywords: HC - Antibodies & Biologics, HC - Diagnostics & Biomarkers, HC - Medical Devices

Leader Research:

Dr. Eitan Lerner

Faculty of Science

  • Contact
Add to Briefcase

Stimuli-responsive nanoparticles for controlled drug delivery and medical applications

pH- and miRNAs-Responsive DNA-Tetrahedra/Metal-Organic Framework Conjugates...
Read more
  • Category: Pharmaceuticals
  • Keywords: HC - Drug Delivery & Formulation, HC - Oncology & Immunotherapy

Leader Research:

Prof. Itamar Willner

Faculty of Science

ADDRESS

Hi-Tech Park, Edmond J. Safra
Campus, Bungalow 2.6
Givat-Ram, Jerusalem
P.O. Box 39135
91390 Israel

CONTACT US
  • Phone: +972-2-658-6688
  • Fax: +972-2-658-6689
  • Email: [email protected]
FOLLOW US
Twitter Linkedin-in Facebook-f Youtube
COPYRIGHT
Twitter Linkedin-in Facebook-f Youtube
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
    • Courses
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
  • Contact Us
Search Our Technologies
Find a Research Expert
Our Portfolio Companies
Briefcase Loading...